Sign Up to like & get
recommendations!
0
Published in 2018 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2018.02784
Abstract: Though promoting remyelination in multiple sclerosis (MS) has emerged as a promising therapeutic strategy, it does not address inflammatory signals that continue to induce neuronal damage and inhibit effectiveness of repair mechanisms. Our lab has…
read more here.
Keywords:
anti inflammatory;
tuftsin combines;
remyelination;
benztropine ... See more keywords